+91-8668442535
Home / Biotechnology / Cell Signa

Cell Signaling Market By Product Type (Antibodies, Reagents, Cellular Assay Kits), By Pathway (PI3K/ AKT Signaling Pathway, AMPK Signaling Pathway, ErbB/Her Signaling Pathway, Hedgehog Signaling Pathway, Hippo Signaling Interactive Pathway, JAK/STAT Signaling Pathway, Notch Signaling Pathway), By Application (Drug Discovery, Adme Studies, Predictive Toxicology Studies, Cancer Research, Stem Cells Research) - Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025

Cell signaling is a complex process of communication that governs the basic activities of cells and coordinates cell actions. Factors such as the growing applicability of cell signaling in biotechnology and medical industries, advancements in cell-based research technology, the growing number of biopharmaceutical industries, and the wide availability of advanced cell signaling are driving the growth of the cell signaling market globally.

The report titled "Cell Signaling Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall cell signaling market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on the pathway, product type, application, and different geographical regions.

Geographically, the global cell signaling market is studied for the following regional markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East and Africa
  • GCC
  • the remainder of MEA

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global cell signaling market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global cell signaling market's competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global cell signaling market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global cell signaling market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on product type, the global cell signaling market is segmented as follows:

  • Antibodies
  • Reagents
  • Cellular Assay Kits
  • Others

Cell signaling is a complex process of communication that governs the basic activities of cells and coordinates cell actions. Cell signaling is necessary for tissue repair, immunity, and normal tissue homeostasis. Furthermore, disruption in cell signaling leads to the development of diseases such as cancer, autoimmunity, and diabetes. Cell signaling is a major field in modern medical practice and diagnosis. Factors such as the growing applicability of cell signaling in R&D, the increase in the incidence of chronic disease, advancements in cell-based research technology, growing biopharmaceutical industries, and the wide availability of different cell signaling products are driving the growth of the cell signaling market globally. For the purpose of the study, the cell signaling market is segmented on the basis of product types, such as antibodies, reagents, cellular assay kits, and other cellular signaling products. It is studied that, in the base year 2016, antibodies held the largest market share due to their wide applicability in molecular biology, increased use in research and the drug discovery process, and their fundamental role in disease detection, structural analysis, sequencing, and mapping, which are driving the growth of the antibodies market in cell signaling.

Based on pathways, the global cell signaling market is segmented as follows:

  • PI3K/AKT Signaling Pathway
  • AMPK signaling pathway
  • ErbB/HER Signaling Pathway
  • Pathway of Hedgehog Signaling
  • Interactive Hippo Signaling Pathway
  • JAK/STAT Signaling Pathway
  • Pathway of Notch Signaling
  • Other cell signaling pathways

Cell signaling governs the basic activities of cells and coordinates cell actions through a complex coordination of responses to the cellular microenvironment. The errors in cell signaling lead to the development of diseases such as cancer, autoimmunity, and diabetes. Cell signaling is a major field in modern medical practice and diagnosis. There are numerous cell signaling pathways that exist; for the purpose of this study, the market is segmented on the basis of pathways such as the AKT signaling pathway, the AMPK signaling pathway, the ErbB/HER signaling pathway, the hedgehog signaling pathway, the hippo signaling interactive pathway, the JAK/STAT signaling pathway, the notch signaling pathway, and other cell signaling pathways. It is observed that, in the base year 2016, the PI3K/AKT signaling pathway was a major revenue-generating segment. As it plays an important role in the regulation of various cellular functions such as metabolism, growth, proliferation, survival, transcription, and protein synthesis, AKT has been implicated in diseases including cancer, diabetes, and neuro-degeneration and is thus widely accepted in basic research and drug development.

Based on application, the global cell signaling market is segmented as follows:

  • Drug Discovery
  • ADME Studies
  • Predictive toxicology studies
  • Cancer Research
  • Stem Cell Study
  • Other Applications

Cell signaling is a complex process through which living cells interact with the cellular environment and neighboring cells. Error or disruption in cell signaling leads to the development of diseases such as cancer, autoimmunity, and diabetes; thus, by understanding cell signaling, diseases may be treated more effectively. Cell signaling has wide applications in the medical and research industries; however, for the purpose of this study, the cell signaling market is segmented on the basis of applications such as drug discovery, ADME studies, predictive toxicology studies, cancer research, stem cell research, and other applications. It is observed that, in the base year 2016, cell signaling applications in cancer research were a major revenue-generating segment and are anticipated to show similar growth during the forecast period. Factors such as the increase in the use of cell signaling techniques in cancer research and drug discovery are prime factors that are driving the growth of cell signaling applications in the cancer research market globally.

For the purpose of this study, the cell signaling market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

It is observed that, in the base year 2016, North America was the largest revenue contributor in the global cell signaling market and occupied a significant portion of the global market; the United States was observed as the largest revenue-generating market in North America. Technological advancement, increased investment in R&D activities, the presence of a large number of biotechnology and biopharmaceutical industries, the presence of a large number of research institutes, and growing life science and biopharmaceutical industries are the primary drivers of cell signaling market growth in North America. However, Asia Pacific will show the highest growth during the forecast period because of increasing government investments in the life sciences sector. Moreover, huge investments in basic research and drug discovery and rapidly expanding biopharmaceutical industries in this region would assist the market's growth during the forecast period. Emerging Asian countries such as China and India are expected to drive market growth [J1] due to increasing R&D activities and growing partnerships of key players with local manufacturers, which would drive cell signaling market growth.

Frequently Asked Questions:

The market for Cell Signaling is expected to reach US$ 4.35 Bn in 2025.

The Cell Signaling market is expected to see significant CAGR growth over the coming years,at 6.4%.

The report is forecasted from 2015-2025.

The base year of this report is 2014.

Abcam plc.,BD Biosciences,Beckman Coulter, Inc.(a subsidiary of Danaher Corporation),Bio-Rad Laborator,BioVision, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Aug 2017
Category:  Biotechnology
Report ID:   58618
Report Format:   PDF
Pages:   120
Rating:    4.8 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support